首页 › 慢性淋巴细胞白血病 › 佛罗里达州 › Tampa
Tampa FL 慢性淋巴细胞白血病临床试验
8项针对 慢性淋巴细胞白血病的研究正在 Tampa及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
招募中1/2 期
- Tampa General Hospital Cancer Institute, Tampa
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
招募中1/2 期
- Moffitt Cancer Center, Tampa
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
招募中3 期
- Moffitt Cancer Center, Tampa
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
招募中1 期
- H. Lee Moffitt Cancer Center, Tampa
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
招募中1/2 期
- Moffitt Cancer Center, Tampa
Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
招募中观察性研究
- Moffitt Cancer Center, Tampa
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
招募中1 期
- Moffitt Cancer Center, Tampa
其他城市的 慢性淋巴细胞白血病试验
- Boston, MA31 项研究
- Columbus, OH28 项研究
- Durham, NC27 项研究
- Washington, DC22 项研究
- Seattle, WA20 项研究
- Rochester, MN18 项研究
- New York City, NY18 项研究
- Houston, TX17 项研究
- Baldwin Park, CA16 项研究
- Milwaukee, WI15 项研究
- Chicago, IL14 项研究
- Cincinnati, OH14 项研究
Tampa的其他研究
- 非小细胞肺癌51 项研究
- 乳腺癌43 项研究
- 癌症（所有类型）39 项研究
- 结直肠癌34 项研究
- 急性髓系白血病29 项研究
- 转移性癌症29 项研究
- 肺癌29 项研究
- 胰腺癌26 项研究
- 卵巢癌21 项研究
- 黑色素瘤19 项研究
- 骨髓增生异常综合征19 项研究
- 前列腺癌18 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。